CA Stock MarketDetailed Quotes
MPH Medicure Inc
- 0.880
- -0.110-11.11%
15min DelayMarket Closed Nov 12 16:00 ET
9.18MMarket Cap-3520P/E (TTM)
0.880High0.870Low4.00KVolume0.870Open0.990Pre Close3.49KTurnover1.59052wk High0.08%Turnover Ratio10.44MShares0.84052wk Low-0.25EPS TTM4.61MFloat Cap131.250Historical HighLossP/E (Static)5.24MShs Float0.075Historical Low-0.09EPS LYR1.01%Amplitude--Dividend TTM0.47P/B1Lot Size--Div YieldTTM
Medicure Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.82%5.17M | 1.17%5.69M | -5.94%21.69M | -19.70%5.07M | -5.39%5M | 4.28%5.99M | -1.54%5.63M | 6.08%23.07M | -7.17%6.32M | 7.48%5.29M |
| Operating revenue | -13.82%5.17M | 1.17%5.69M | -5.94%21.69M | -19.70%5.07M | -5.39%5M | 4.28%5.99M | -1.54%5.63M | 6.08%23.07M | -7.17%6.32M | 7.48%5.29M |
| Cost of revenue | 22.60%2.21M | -1.91%1.8M | 10.23%7.71M | 38.34%2.71M | -2.08%1.36M | -7.53%1.81M | 8.34%1.83M | -22.61%6.99M | -35.25%1.96M | -31.71%1.39M |
| Gross profit | -29.51%2.95M | 2.66%3.9M | -12.98%13.99M | -45.74%2.37M | -6.57%3.64M | 10.36%4.19M | -5.69%3.8M | 26.46%16.08M | 15.26%4.36M | 35.18%3.9M |
| Operating expense | 5.41%4.07M | 11.21%3.86M | -0.26%14.84M | 0.84%3.96M | 16.59%3.55M | -15.31%3.86M | 3.61%3.47M | 0.52%14.88M | 13.79%3.93M | -15.61%3.04M |
| Selling and administrative expenses | 0.28%3.2M | 8.12%3.18M | 2.55%12.44M | 3.17%3.26M | 11.39%3.04M | -1.30%3.19M | -2.00%2.94M | -6.77%12.13M | -7.39%3.16M | -13.03%2.73M |
| -Selling and marketing expense | -11.32%1.83M | -3.14%1.97M | 4.68%8.31M | -24.07%2.18M | 19.07%2.02M | 23.54%2.07M | 20.45%2.04M | -23.05%7.94M | 19.39%2.88M | -34.87%1.69M |
| -General and administrative expense | 21.60%1.37M | 33.44%1.21M | -1.48%4.13M | 278.87%1.08M | -1.16%1.02M | -27.93%1.13M | -30.95%906K | 55.47%4.19M | -71.68%284K | 92.57%1.04M |
| Research and development costs | 29.94%868K | 28.52%676K | -12.64%2.41M | -8.70%703K | 61.78%508K | -49.55%668K | 52.46%526K | 53.34%2.75M | 1,733.33%770K | -32.91%314K |
| Operating profit | -441.90%-1.12M | -88.34%38K | -171.58%-854K | -471.40%-1.6M | -89.32%91K | 142.80%327K | -51.78%326K | 157.00%1.19M | 30.70%430K | 217.52%852K |
| Net non-operating interest income (expenses) | 63.64%36K | 1,120.00%51K | 140.12%65K | 162.50%45K | 109.09%3K | 157.89%22K | 73.68%-5K | 35.46%-162K | -366.67%-72K | 17.50%-33K |
| Non-operating interest income | ---- | ---- | 650.00%75K | ---- | ---- | ---- | ---- | -87.18%10K | ---- | ---- |
| Non-operating interest expense | ---- | ---- | 186.96%20K | ---- | ---- | ---- | ---- | -160.53%-23K | ---- | ---- |
| Total other finance cost | -63.64%-36K | -1,120.00%-51K | -105.13%-10K | -90.48%10K | -109.09%-3K | -157.89%-22K | --5K | -32.99%195K | 707.69%105K | -17.50%33K |
| Other net income (expenses) | 16.67%-25K | 70.83%-7K | -130.51%-108K | -148.05%-37K | -105.45%-17K | -130.61%-30K | 81.95%-24K | -77.67%354K | -94.85%77K | 238.05%312K |
| Gain on sale of security | 16.67%-25K | 70.83%-7K | -307.69%-108K | -148.05%-37K | -270.00%-17K | -130.61%-30K | 81.95%-24K | 67.74%52K | -82.18%77K | 104.42%10K |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 83.94%-44K | 54.77%-346K | --302K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -83.94%44K | -54.77%346K | ---302K |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.07%346K | ---- | ---- |
| Income before tax | -447.02%-1.11M | -72.39%82K | -164.77%-897K | -465.29%-1.59M | -93.19%77K | 145.31%319K | -43.32%297K | 282.48%1.39M | -76.50%435K | 214.13%1.13M |
| Income tax | 66.67%110K | 342.86%31K | 25.00%25K | -115.79%-41K | -138.89%-7K | 414.29%66K | -83.33%7K | 162.50%20K | 66.07%-19K | 140.00%18K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -581.03%-1.22M | -82.41%51K | -167.55%-922K | -440.97%-1.55M | -92.45%84K | 137.04%253K | -39.83%290K | 287.76%1.37M | -76.19%454K | 217.65%1.11M |
| Net income continuous operations | -581.03%-1.22M | -82.41%51K | -167.55%-922K | -440.97%-1.55M | -92.45%84K | 137.04%253K | -39.83%290K | 287.76%1.37M | -76.19%454K | 217.65%1.11M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -581.03%-1.22M | -82.41%51K | -167.55%-922K | -440.97%-1.55M | -92.45%84K | 137.04%253K | -39.83%290K | 287.76%1.37M | -76.19%454K | 217.65%1.11M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -581.03%-1.22M | -82.41%51K | -167.55%-922K | -440.97%-1.55M | -92.45%84K | 137.04%253K | -39.83%290K | 287.76%1.37M | -76.19%454K | 217.65%1.11M |
| Diluted earnings per share | -700.00%-0.12 | -83.71%0.0049 | -169.23%-0.09 | -475.00%-0.15 | -90.91%0.01 | 133.33%0.02 | -40.00%0.03 | 285.71%0.13 | -78.95%0.04 | 222.22%0.11 |
| Basic earnings per share | -700.00%-0.12 | -83.71%0.0049 | -169.23%-0.09 | -475.00%-0.15 | -90.91%0.01 | 133.33%0.02 | -40.00%0.03 | 285.71%0.13 | -78.95%0.04 | 222.22%0.11 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data